NGLFINE vs ZIMLAB: Stock Comparison

NGL Fine-Chem Limited vs Zim Laboratories Limited

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

NGL Fine-Chem Limited is the larger company by market capitalisation. NGL Fine-Chem Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of NGL Fine-Chem Limited and Zim Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, NGLFINE is more favourable on 12 of 13 scored metrics and ZIMLAB on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NGLFINE is the larger company
₹2,008 Cr vs ₹656 Cr
P/E Ratio
NGLFINE has a lower P/E
41.23x vs 112.39x
P/B Ratio
ZIMLAB has a lower P/B
2.21x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹1.94
Dividend Yield
NGLFINE has a higher dividend yield
0.05% vs 0.02%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs -3.36%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -47.01%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -12.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNGLFINEZIMLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricNGLFINEZIMLAB
Live Price₹3,260₹104.91
Day Change0.7%0.25%
Volume5,59581,241
52-Week High₹3,329₹121.47
52-Week Low₹1,175.5₹59.31
Distance from 52W High-2.07%-13.63%

Valuation

MetricNGLFINEZIMLAB
Market Cap₹2,008 Cr₹656 Cr
P/E Ratio41.23x112.39x
P/B Ratio6.03x2.21x
EPS₹78.04₹1.94
Book Value₹532.95₹51.77
Dividend Yield0.05%0.02%

Growth

MetricNGLFINEZIMLAB
Revenue Growth (TTM YoY)57.2%-3.36%
EPS Growth (TTM YoY)1,539.8%-47.01%
Qtr Sales Growth57.1%-12.3%
Qtr Profit Growth2,398%-308%

Profitability & Leverage

MetricNGLFINEZIMLAB
ROE15.7%1.97%
ROCE17%8.16%
Net Margin9.59%1.56%
Operating Margin14.5%5.72%
Debt to Equity0.33x0.42x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricNGLFINEZIMLAB
Promoter Holding72.74%30.36% 0.01 pp
FII Holding0.03% 0.03 pp0.03% 0.03 pp
DII Holding0%1.33% 1.26 pp
Public Holding27.24% 0.02 pp68.28% 1.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL Fine-Chem Limited and Zim Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.